ArticleThe Lancet. Global health2022
Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling study.
Article in The Lancet. Global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 38 citations in OpenAlex.
- Cost-effectiveness and budget impact analyses of strategies to improve measles vaccination coverage in Kenya.PLOS global public health · 2026Article
- Adverse events following measles, mumps, rubella and varicella virus vaccine live (PROQUADVirology journal · 2025Article
- COVID-19 pandemic and waning immunity disrupted measles population immunity and strategies to close immunity gaps.Nature communications · 2025Article
- Article
- Improving policy design and epidemic response using integrated models of economic choice and disease dynamics with behavioral feedback.PLoS computational biology · 2025Article
- Factors determining the overlap between recipients of the first and second dose of measles vaccine in nineteen surveys.Scientific reports · 2025Article
- Can implementation research be a game changer for measles elimination in Africa?The Pan African medical journal · 2025Article
- Article
- Article
- Article
- Article
- Article
- Possible Paths to Measles Eradication: Conceptual Frameworks, Strategies, and Tactics.Vaccines · 2024Review
- Case Ascertainment of Measles during a Large Outbreak-Laboratory Compared to Epidemiological Confirmation.Diagnostics (Basel, Switzerland) · 2024Article
- Article
- Progress Toward Rubella and Congenital Rubella Syndrome Elimination - Worldwide, 2012-2022.MMWR. Morbidity and mortality weekly report · 2024Article
- Article
- Measles virus transmission patterns and public health responses during Operation Allies Welcome: a descriptive epidemiological study.The Lancet. Public health · 2023Article
- Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries.BMJ global health · 2023Article
- Exploring potential applications of measles and rubella microarray patches (MR-MAPs): use case identification.Frontiers in public health · 2023Article
Corrections and comments
- Commented on by
Authors and funding
18 authors at 11 institutions in 4 countries.
Funding
Abstract
backgroundMarked reductions in the incidence of measles and rubella have been observed since the widespread use of the measles and rubella vaccines. Although no global goal for measles eradication has been established, all six WHO regions have set measles elimination targets. However, a gap remains between current control levels and elimination targets, as shown by large measles outbreaks between 2017 and 2019. We aimed to model the potential for measles and rubella elimination globally to inform a WHO report to the 73rd World Health Assembly on the feasibility of measles and rubella eradication.
methodsIn this study, we modelled the probability of measles and rubella elimination between 2020 and 2100 under different vaccination scenarios in 93 countries of interest. We evaluated measles and rubella burden and elimination across two national transmission models each (Dynamic Measles Immunisation Calculation Engine [DynaMICE], Pennsylvania State University [PSU], Johns Hopkins University, and Public Health England models), and one subnational measles transmission model (Institute for Disease Modeling model). The vaccination scenarios included a so-called business as usual approach, which continues present vaccination coverage, and an intensified investment approach, which increases coverage into the future. The annual numbers of infections projected by each model, country, and vaccination scenario were used to explore if, when, and for how long the infections would be below a threshold for elimination.
findingsThe intensified investment scenario led to large reductions in measles and rubella incidence and burden. Rubella elimination is likely to be achievable in all countries and measles elimination is likely in some countries, but not all. The PSU and DynaMICE national measles models estimated that by 2050, the probability of elimination would exceed 75% in 14 (16%) and 36 (39%) of 93 modelled countries, respectively. The subnational model of measles transmission highlighted inequity in routine coverage as a likely driver of the continuance of endemic measles transmission in a subset of countries.
interpretationTo reach regional elimination goals, it will be necessary to innovate vaccination strategies and technologies that increase spatial equity of routine vaccination, in addition to investing in existing surveillance and outbreak response programmes.
fundingWHO, Gavi, the Vaccine Alliance, US Centers for Disease Control and Prevention, and the Bill & Melinda Gates Foundation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.